Peter De Brouwer

Internal mammary and medial supraclavicular lymph node chain irradiation in stage I–III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trial

Philip Poortmans, Caroline Weltens, Catherine Fortpied et al. · The Lancet Oncology · 2020 · 288 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Brain metastases and non-small cell lung cancer. Prognostic factors and correlation with survival after irradiation

Patrick Rodrigus, Peter De Brouwer, Esther Raaymakers · Lung Cancer · 2001 · 91 citations

Medicine, Oncology, Radiation Oncology +15

Side Effects 15 Years After Lymph Node Irradiation in Breast Cancer: Randomized EORTC Trial 22922/10925

Philip Poortmans, H. Struikmans, Peter De Brouwer et al. · JNCI Journal of the National Cancer Institute · 2021 · 48 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Entrance and exit TL-dosimetry in the conservative treatment of breast cancer: a pilot study for the EORTC-radiotherapy cooperative group

Han Hamers, Kjell Arne Johansson, J.L.M. Venselaar et al. · Radiotherapy and Oncology · 1991 · 35 citations

Medicine, Oncology, Radiation Oncology +17

Risk of diabetes after para-aortic radiation for testicular cancer

Harmke J. Groot, Jourik A. Gietema, Berthe M.P. Aleman et al. · British Journal of Cancer · 2018 · 21 citations · Full text

Medicine, Oncology, Radiation Oncology +17